2008 - Risk for cancer was still increased over 2 years after stopping hormone therapy

Cheung, Angela M.
August 2008
ACP Journal Club;8/19/2008, Vol. 149 Issue 2, p9
Academic Journal
The article focuses on a study regarding the health risks associated in postmenopausal women after stopping hormone therapy (HT) and presents the author's views on it. It describes the procedure of the study, which revealed that the risk of cancer increased in postmenopausal women, over 2 years after stopping estrogen and progestin therapy. The author suggests that postmenopausal women should weigh the benefits and risks of HT and use the lowest dose for the shortest possible duration.


Related Articles

  • Hormone Replacement Therapy, Reproductive Factors, and Cataract The Blue Mountains Eye Study. Cumming, Robert G.; Mitchell, Paul // American Journal of Epidemiology;1997, Vol. 145 Issue 3, p242 

    The relation between estrogen (endogenous and exogenous) and cataract is unclear, with one large population-based study recently suggesting a protective effect of estrogen replacement therapy. The study reported in this paper, the Blue Mountains Eye Study, was conducted in Australia in...

  • Evidence for hormone replacement therapy.  // Gastrointestinal Nursing;Feb2009, Vol. 7 Issue 1, p6 

    The article focuses on the study conducted by University of Minnesota School of Public Health on hormone replacement therapy (HRT). It says that 45% of developing bowel cancer was reduced among postmenopausal women who took oestrogen and progestogen-HRT, 25% to those who took oestrogen-only HRT,...

  • Hormone Replacement and Breast Cancer. Klotter, Jule // Townsend Letter;Aug/Sep2013, Issue 361/362, p34 

    The article discusses the study "Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study," by T. Rowan Chlebowski and colleagues, published in the March 29, 2013 online issue of "Journal of the National Cancer Institute." It suggests...

  • TRATAMENTO DOS SINTOMAS DO CLIMAT�RIO UTILIZANDO MEDICAMENTO FITOTER�PICO: ESTUDO DE REVIS�O. Cavalcante De Souza, Andr�ia; Yasuo Oda, Juliano // UNING� Review;2012, Vol. 10 Issue 1, p75 

    With the increase of the life expectancy of the women for 76 years they start to survive long enough to experience changes in their body as that climacteric that consists in a phase of woman's life where there is transition from the reproductive or fertile period for non-reproductive one, after...

  • Utilidad clinica de la dosificación de hormonas ováricas. GÓMEZ MONT, Francisco // Ginecologia y Obstetricia de Mexico;abr2011, Vol. 79 Issue 4, p252 

    No abstract available.

  • HRT may raise women's kidney stone risk.  // GP: General Practitioner;10/15/2010, p9 

    The article focuses on a study, published in the "Archives of Internal Medicine," on the impact of hormone replacement therapy (HRT) on a woman's health. A team of U.S.-based researchers analyzed data of postmenopausal women who underwent HRT and found that HRT may increase the risk of kidney...

  • Estrogen-Plus-Progestin Use and Mammographic Density in Postmenopausal Women: Women's Health Initiative Randomized Trial. McTiernan, Anne; Martin, Christopher F.; Peck, Jennifer D.; Aragaki, Aaron K.; Chlebowski, Rowan T.; Pisano, Etta D.; Wang, C. Y.; Brunner, Robert L.; Johnson, Karen C.; Manson, JoAnn E.; Lewis, Cora E.; Kotchen, Jane M.; Hulka, Barbara S. // JNCI: Journal of the National Cancer Institute;9/21/2005, Vol. 97 Issue 18, p1366 

    Background: Increased mammographic density reduces the sensitivity of screening mammography, is associated with increased breast cancer risk, and may be hormone related. We assessed the effect of estrogen-plus-progestin therapy on mammographic density. Methods: In a racially and ethnically...

  • Estrogen alone provides protective effect to reduce breast cancer risk.  // Hem/Onc Today;1/25/2011, Vol. 12 Issue 2, p16 

    The article discusses research being done by oncologist Joseph Ragaz on the physiological effect of hormone replacement with exogenous estrogen on women.

  • Estrogen plus progestin increased risk for breast cancer in postmenopausal women.  // ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p61 

    In postmenopausal women, estrogen plus progestin hormone therapy (HT) increases cases of total and invasive breast cancer and abnormal mammogram results. Women who have received HT had a greater incidence of total and invasive breast cancer than did women who received placebo. The increase in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics